Company Badge
USPTO Data Jan 1 1976 - Oct 6 2026
5 Patents
#29 in Baton Rouge, LA
#189 in Louisiana
#51,570 in US
Transgenrx, Inc.
Forward Citations = 137
5 inventors:
Baton Rouge, LA, United States of America
Transgenrx, Inc.
% Expired Patents = 100.0
Forward Citations = 137
Loading Chart...
Loading Chart...
5 inventors (with patents filed for the assignee):
Richard K Cooper (5 out of 14 patents)
William C Fioretti (5 out of 16 patents)
Gary G Cadd (3 out of 3 patents)
4. Frederick M Enright (2 out of 13 patents)
5. Kenneth F De Boer (2 out of 2 patents)
5 patents:
Company Overview
Transgenrx, Inc. is a biotechnology company specializing in the development of innovative gene therapies for a range of genetic disorders. With a focus on personalized medicine, Transgenrx aims to revolutionize the field of gene therapy and improve the lives of patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Transgenrx, Inc.. Retrieved from https://idiyas.com/company/transgenrx
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]